EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Resveratrol’s potential in the prevention and treatment of neurodegenerative diseases: molecular mechanisms

Mac Dionys Rodrigues da Costa, Izabell Maria Martins Teixeira, Bruna Ribeiro Duque, Natasha Maria Lima Pinheiro, Cauan Farias Ananias, Mateus Oliveira Fernandes, Larissa Holanda e Silva, Hugo Leonardo Pereira Filho, Glautemberg de Almeida Viana, Emanuel Paula Magalhães, Ramon Róseo Paula Pessoa Bezerra de Menezes, Alice Maria Costa Martins und 1 weitere

Exploration of Neuroprotective Therapy · 2025

DOI: 10.37349/ent.2025.1004124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Neuroprotective Therapy, 2025. Verfasst von Mac Dionys Rodrigues da Costa und 12 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing prevalence of neurodegenerative diseases (NDs), such as Alzheimer’s, Parkinson’s, Huntington’s, multiple sclerosis, and amyotrophic lateral sclerosis, represents a serious global public health issue. Consequently, the search for compounds with neuroprotective potential has intensified. In this context, resveratrol (RSV), a stilbene polyphenol found mainly in red grapes, exhibits important pharmacological properties, such as antioxidant and anti-inflammatory, and has been widely investigated in neuroscience due to its potential in the prevention and treatment of NDs. This narrative review was conducted using the PubMed® database, with the keywords “resveratrol”, “molecular mechanisms”, “mechanisms of action”, “neuroinflammation”, “oxidative stress”, “autophagy”, “gene regulation”, and “clinical studies”. This study discusses the molecular mechanisms of RSV on NDs, focusing on signaling pathways involved in neuroinflammation, oxidative stress, gene regulation, autophagy, and cell death. Intracellular pathways such as NF-κB, JAK/STAT, MAPK/ERK, PI3K/Akt, and Nrf2/Keap1 are associated with immune modulation mediated by RSV, leading to a decrease in oxidative stress, induction of autophagy, and inhibition of apoptosis. RSV has pharmacokinetic limitations, such as low bioavailability and stability, although RSV can cross the blood-brain barrier. Thus, researches involving nonencapsulated formulations aim to enhance their delivery to the central nervous system. Current in vitro and in vivo studies are promising, although further clinical trials are needed, as few have been conducted and available data remain preliminary. In conclusion, RSV presents multiple benefits to neurological health and shows therapeutic potential in NDs; however, additional clinical studies and translational research are essential to validate and optimize its application.

Zitieren

APA

Costa, M. D. R. D., Teixeira, I. M. M., Duque, B. R., Pinheiro, N. M. L., Ananias, C. F., Fernandes, M. O., Silva, L. H. E., Filho, H. L. P., Viana, G. D. A., Magalhães, E. P., Menezes, R. R. P. P. B. D., Martins, A. M. C., & Sampaio, T. L. (2025). Resveratrol’s potential in the prevention and treatment of neurodegenerative diseases: molecular mechanisms. Exploration of Neuroprotective Therapy. https://doi.org/10.37349/ent.2025.1004124

Vancouver

Costa MDRD, Teixeira IMM, Duque BR, Pinheiro NML, Ananias CF, Fernandes MO, et al. Resveratrol’s potential in the prevention and treatment of neurodegenerative diseases: molecular mechanisms. Exploration of Neuroprotective Therapy. 2025. doi:10.37349/ent.2025.1004124

BibTeX
@article{Costa2025,
  author = {Costa, Mac Dionys Rodrigues da and Teixeira, Izabell Maria Martins and Duque, Bruna Ribeiro and Pinheiro, Natasha Maria Lima and Ananias, Cauan Farias and Fernandes, Mateus Oliveira and Silva, Larissa Holanda e and Filho, Hugo Leonardo Pereira and Viana, Glautemberg de Almeida and Magalhães, Emanuel Paula and Menezes, Ramon Róseo Paula Pessoa Bezerra de and Martins, Alice Maria Costa and Sampaio, Tiago Lima},
  title = {Resveratrol’s potential in the prevention and treatment of neurodegenerative diseases: molecular mechanisms},
  journal = {Exploration of Neuroprotective Therapy},
  year = {2025},
  doi = {10.37349/ent.2025.1004124}
}
Kostenlos starten →